Luxembourg vs Mauritania: Previously treated cases tested for RR-/MDR-TB
Luxembourg
100.0%
in 2024
Mauritania
100.0%
in 2023
Luxembourg rank
1st
Mauritania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Luxembourg
- Mauritania
How they compare
Luxembourg currently reports 100.0% against 100.0% in Mauritania, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2011 it was Luxembourg ahead.
Luxembourg ranks 1st and Mauritania ranks 1st of 180 countries.
Across the 2 decades both report, Luxembourg averaged higher in 1 and Mauritania in 1.
Head to head by decade
| Decade | Luxembourg | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 3.9% | 96.1% | Luxembourg |
| 2020s | 93.8% | 100.0% | 6.2% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Luxembourg or Mauritania?
- Luxembourg, at 100.0% against 100.0% in Mauritania as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Luxembourg and Mauritania?
- 0.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Mauritania?
- 5 years are reported by both, from 2011 to 2023.
- How do Luxembourg and Mauritania rank globally for previously treated cases tested for rr-/mdr-tb?
- Luxembourg ranks 1st and Mauritania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.